ECT FOR NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA: DATA FROM A TERTIARY PSYCHIATRY CLINIC


Creative Commons License

Aksoy Poyraz C., Çetiner Batun G., Usta Sağlam N. G., Özdemir A., Poyraz B. Ç., Duran A.

167th Annual Meeting of the American Psychiatric Association , New York, Amerika Birleşik Devletleri, 3 - 07 Mayıs 2014, ss.462, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: New York
  • Basıldığı Ülke: Amerika Birleşik Devletleri
  • Sayfa Sayıları: ss.462
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background: :ECT has been shown to be an effective treatment for patients with schizophrenia presented with catatonia, depression, mania and other prominent affective features. ECT is currently underused in many psychiatric settings due to the stigmatized perception of patients, their families and mental health professionals. Aim: The aims of the study were to describe the indications for ECT among patients admitted with acute psychotic episode to a tertiary psychiatric department in Turkey. We also aimed at assessing whether patients with schizophrenia who received ECT differed in their clinical history, diagnosis, severity of illness, psychopathology, and duration of hospital stay, compared to patients who did not receive it. Methods: This was a naturalistic prospective study of 32 patients admitted with acute exacerbation of psychosis, 8 (25 %) of which received ECT. The sociodemographic details, past psychiatric history, comorbid personality, and substance use details were recorded by a semi-structured interview method. Clinical diagnosis was confirmed by two consultant psychiatrists based on DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders). Psychopathology was assessed within 3 days of admission and just prior to discharge using the Positive and Negative Syndrome Scale (PANSS). Total duration of the stay in the hospital was also recorded. Results: In patients who received ECT (n=8) the major indication was to augment pharmacotherapy. Drug choice was similar between groups. Duration of hospitalization was longer in the ECT group compared to teh group of patients which didn’t receive ECT (mean: 34 days vs 26, p=0.04). Severity of negative symptoms in admission was significantly higher in patients who received ECT (33.7 vs 27, p=0.025, u:83). The decrease in negative symptoms between admission and discharge was higher in ECT group, although the difference didn’t reach statistical significance (mean:17 in ECT group versus 11.3 in non-ECT group, p=0.1). Conclusion: This preliminary study indicates a preference among treating physicians for ECT in the presence of more severe negative symptoms in schizophrenia. Also, further studies aiming to test whether ECT could be effective in ameliorating the negative symptoms in schizophrenia might be warranted